Treatment Access A Substance Use Disorder Perspective

Slides:



Advertisements
Similar presentations
TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
Advertisements

Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Single State Agency responsible for planning, coordination and regulation of the statewide network of prevention, intervention, treatment and recovery.
DMAS Office of Behavioral Health
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Susan Jenkins October Over 47 million non-elderly Americans were uninsured in Decreasing the number of uninsured is a key goal of the Affordable.
Prescription Drug Abuse and Misuse in the Elderly Thomas L. Patterson, Ph.D. Support for this work: NIMH Center Grants P30 MH49693 and MH45131, and by.
Rehabilitation Programs and Office Follow-up Steven R. Ey, M.D. Medical Director Genesis Chemical Dependency Unit South Coast Medical Center Laguna Beach,
H Department of Medical Assistance Services Substance Abuse Intensive Outpatient – SA IOP 2013.
 Professional society founded in 1954 representing 3,100+ physicians & other associated professionals  Mission:  Increase access to & improve the quality.
"Meeting Challenges: Trying to Stay One Step Ahead" Steve Hanson Associate Commissioner Treatment & Practice Innovation.
Mrs. Wilson ’ s Alfre Inc Treatment Services for Women.
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
KENTUCKY YOUTH FIRST Grant Period August July
Co-occurring Challenges: Leveraging ADAP and ACA to Address Hepatitis C and Substance Use Disorders Daniel Raymond Policy Director Harm Reduction Coalition.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
FEHB, Federal Worksites, and Women’s Health Aligning for Success 1 Christine Hunter MD December 2, 2015.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Health Reform: Is Your Community Ready for 2014? Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention 2011 School for Prevention.
1 Center Mission Statements SAMHSA ? CSAT Improving the Health of the Nation by Bringing Effective Alcohol and Drug Treatment to Every Community CMHS Caring.
H Department of Medical Assistance Services Substance Abuse Day Treatment 2013.
Medication Assisted Treatment for Opioid Use Disorders
Public SUD Treatment ●Information on SUD treatment is provided by data that are reported routinely to the national SUD treatment monitoring system known.
2016 National Training Program Medicare, Medicaid, and Marketplace Coverage for Substance Use Disorders July 2016.
Substance Exposed Newborns: Addressing Substance Use Disorder
Wireless Access SSID: cwag2017
Addressing Mental Health and Substance Use Disorders in Veterans
Substance Abuse Treatment in the FQHC: Managing the Opioid Crisis
Clinical Committee for DMC-ODS EQRO – September 16 Mtg
screening, brief intervention and referral to treatment
Wireless Access SSID: cwag2017
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
CHAPTER 1: Introduction
US Census Data Ortman, Jennifer M., Victoria A. Velkoff, and Howard Hogan. An Aging Nation: The Older Population in the United States, Current Population.
Illinois’ 1115 Behavioral Health Transformation Waiver
Levels of Care Continuum of Care ASAM Patient Placement Criteria (PPC)
National Health Reform is Essential
Medication-Assisted Therapy at Coleman Profession Services
Neonatal Abstinence Syndrome (NAS) Program Overview
Public Substance Use Disorder Treatment for Youth in California County Behavioral Health Directors Association of California – All Members Meeting October.
Katherine Neuhausen, MD, MPH Chief Medical Officer
Addiction: A Love/Hate Relationship
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
Nick Szubiak, MSW, LCSW Director, Clinical Excellence in Addictions
Addiction and the Opioid Crisis: HHS Update
Opioid Prescribing & Monitoring
Medication Assisted Treatment
Gary Mendell, Founder and CEO
MDHHS Response to the Opioid Crisis
Bevin K. Shagoury, Communications & Education Director
Developing and Using a Referral Network
CC2.0 Behavioral Health 1115 Waiver Proposals August 6, 2018
Pain Management and Substance Use Disorders: JCPP Strategic Session
West Virginia Medicaid Summit
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Understanding and Using ASAM Criteria
The US is facing an unprecedented opioid epidemic, which has resulted in increases health care services utilization and a surge in overdose deaths. Medicaid.
Addiction Treatment Program North Canyon Medical Center
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
Are you sick and tired of being sick and tired?
Strategic Initiatives to Address Opioid Overdose & Addiction
Colorado Opioid Task Force
Medication Assisted Treatment of Opioid Use Disorder
Transforming the Delivery of Substance Use Disorder Treatment in States Update August 2019.
The Silent Killer in America
Presentation transcript:

Treatment Access A Substance Use Disorder Perspective National Foundation for Women Legislators September 22, 2017 Alaina McBournie, Principal Associate | Substance Use Prevention and Treatment Initiative

Reduce the inappropriate use of prescription opioids while ensuring that patients with medical needs have access to pain control, and Expand access to effective treatment for substance use disorders, including medication-assisted treatment.

Presentation Outline Overview of Opioid Use Disorders (OUD) Evidence-Based Treatment Barriers and Solutions to Improve Treatment Access

SOURCE: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health (NSDUH), 2015.; Facing Addiction Action Network, https://www.facingaddiction.org/home/fact-16-surgeongeneral-stat.

Opioid Use Disorder… is a complex disease that results in chemical and physiologic changes to the brain must be treated like any other chronic, relapsing condition

Medication-Assisted Treatment (MAT) is Effective Medication-assisted treatment increases adherence and reduces: Illicit opioid use Overdose risk and fatalities Health care utilization Criminal activity Mattick RP et al., 2009;3:CD002209; Comer SD et al. JAMA Psych. 2006;63:210-8; Fudala PJ et al., NEJM. 2003;10:949-58; Schwartz RP et al. AJPH. 2013;103,917-22;. Tsui JI et al. JAMA Intern Med. 2014;174:1974-81; Metzger DS et al., J Acquir Immune Defic Syndr. 1993;6:1049-56.

Medications for Opioid Use Disorder The Pew Charitable Trusts, “http://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2016/11/medication-assisted-treatment-improves-outcomes-for-patients-with-opioid-use-disorder.

Behavioral Therapies for Opioid Use Disorder Goals Modify underlying behaviors that lead to misuse Support medication adherence Example cognitive behavioral therapies Individual or group counseling Family therapy Mutual help programs

Guidelines from the American Society of Addiction Medicine (ASAM) Recommend coverage for: FDA-approved drugs Counseling and long-term recovery supports Guidelines address: Disease severity Setting of care http://www.asam.org/quality-practice/guidelines-and-consensus-documents/npg/pocket-guide-and-app

ASAM Criteria Use Disease Severity to Determine Treatment Needs 2 Intensive Outpatient and Partial Hospitalization 1 Outpatient Treatment .5 Early Intervention 3 Residential/Inpatient Treatment 4 Medically-Managed Intensive Inpatient Treatment SOURCE: American Society of Addiction Medicine http://www.asam.org/quality-practice/guidelines-and-consensus-documents/the-asam-criteria/about

In practice, many public and private payers fail to cover all of the care recommended by the ASAM guidelines.

Medicaid Programs in 19 States Do Not Cover All Drugs for Opioid Use Disorder Colleen M. Grogan et al., “Survey Highlights Differences In Medicaid Coverage For Substance Use Disorder Treatment And Opioid Use Disorder Medications,” Health Affairs 35, no. 12 (2016), http://content.healthaffairs.org/content/35/12/2289.full.

Residential Treatment is Often Not Covered by Medicaid ASAM Levels of Care Coverage All Levels Covered Missing One or More Levels Source: Colleen M. Grogan et al., “Survey Highlights Differences In Medicaid Coverage For Substance Use Disorder Treatment And Opioid Use Disorder Medications,” Health Affairs 35, no. 12 (2016), http://content.healthaffairs.org/content/35/12/2289.full.

Barriers to an Effective Treatment System Coverage Gaps Treatment Infrastructure Funding

The GOAL is… an effective treatment system that provides timely access to comprehensive and evidence-based care.

Summary Opioid use disorder is a chronic disease A comprehensive and evidence-based treatment approach is needed Medication-assisted treatment is effective, but barriers exist Access to effective treatment requires input from patients, clinicians, insurers, and state and federal policymakers

ALAINA MCBOURNIE amcbournie@pewtrusts.org 202-540-6967 www.pewtrusts.org/substancemisuse